Jazz Pharmaceuticals (JAZZ) Non-cash Items (2011)

Jazz Pharmaceuticals (JAZZ) recorded quarterly Non-cash Items of $3.6 million in Q4 2011.

Jazz Pharmaceuticals (JAZZ) Non-cash Items (2011) Analysis & Trends

Jazz Pharmaceuticals' Non-cash Items history runs 1 years deep, the most recent figure standing at $3.6 million for Q4 2011.

In Q4 2011, Non-cash Items changed N/A year-over-year to $3.6 million; the TTM figure through Dec 2011 stood at $3.6 million (changed N/A YoY), while the FY2011 annual figure was $3.6 million, changed N/A from the prior year.
Non-cash Items was $3.6 million for Q4 2011 at Jazz Pharmaceuticals.
In the past five years, Non-cash Items ranged from a high of $3.6 million in Q4 2011 to a low of $3.6 million in Q4 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Jazz Pharmaceuticals	13.91 Bn	12.06 Bn	934.80 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2011	3.65 Mn
Dec 31, 2011	3.65 Mn